ABPI response to latest NICE Methods Review

19 August 2021 Posted in News by Press Office

NICE has launched a consultation on proposed changes to its methods, processes and topic selection for health technology evaluation.

This is a major milestone in an important review, and a significant opportunity to update the methods and processes NICE uses to support access to the life-changing medicines of today and tomorrow. Richard Torbett

In response, Richard Torbett, Chief Executive of the ABPI, said:

“This is a major milestone in an important review, and a significant opportunity to update the methods and processes NICE uses to support access to the life-changing medicines of today and tomorrow.

“The ABPI and our members will be working hard over the coming months to help make sure the proposals meet the ambition of the UK’s Life Sciences Vision and deliver meaningful change for patients, their families, and the NHS.”

TAGS
  • NICE Methods Review

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.

Media enquiries

+44 (0) 20 7747 7147​​